湖北华世通生物医药科技有限公司
Waterstone Pharmaceuticals Hubei Co. Ltd.
Country: CN CDE+DMF VERY_HIGH
🇨🇳 CDE
11
11 products shown
🇺🇸 DMF
13
13 products shown
🇪🇺 CEP
0
0 products shown
Total
24
registrations
🇨🇳 CDE 注册 (11)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Alogliptin Benzoate 苯甲酸阿格列汀 | 850649-61-5 | Class A | Y20170002172 |
| Canagliflozin 卡格列净 | 842133-18-0 | Class A | Y20200001380 |
| Celecoxib 塞来昔布 | 169590-42-5 | Class A | Y20170000767 |
| Colesevelam 盐酸考来维仑 | - | Class I | Y20220000841 |
| Deferasirox 地拉罗司 | 201530-41-8 | Class A | Y20200000681 |
| Febuxostat 非布司他 | 144060-53-7 | Class A | Y20180001003 |
| Lamotrigine 拉莫三嗪 | 84057-84-1 | Class A | Y20170000392 |
| On123300 HX301 | 1357470-29-1 | Class I | Y20190000947 |
| Sevelamer 碳酸司维拉姆 | - | Class A | Y20220000545 |
| Tadalafil 他达拉非 | 171596-29-5 | Class A | Y20210001009 |
| Vidarabine 单磷酸阿糖腺苷 | 5536-17-4 | Class A | Y20190006214 |
🇺🇸 DMF 注册 (13)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Celecoxib 塞来昔布 | 169590-42-5 | 27872 | 2013-12-04 |
| Colesevelam Hydrochloride 盐酸考来维仑 | 182815-44-7 | 37431 | 2022-12-22 |
| Deferasirox 地拉罗司 | 201530-41-8 | 41202 | 2025-04-01 |
| Dexlansoprazole 右兰索拉唑 | 138530-94-6 | 29346 | 2015-05-19 |
| Ezetimibe 依折麦布 | 163222-33-1 | 28942 | 2014-12-04 |
| Febuxostat 非布司他 | 144060-53-7 | 26549 | 2012-09-25 |
| L-ala-paf-oh Hcl | - | 27558 | 2013-08-25 |
| Lamotrigine 拉莫三嗪 | 84057-84-1 | 25775 | 2011-12-30 |
| Lansoprazole 兰索拉唑 | 103577-45-3 | 28380 | 2014-05-20 |
| Levetiracetam 左乙拉西坦 | 102767-28-2 | 26194 | 2012-06-25 |
| Monomethyl Auristatin E (mmae) | 474645-27-7 | 38589 | 2024-07-31 |
| Payload-linker Vcmmae | - | 38590 | 2025-04-21 |
| Sevelamer Carbonate 司维拉姆 | 845273-93-0 | 36929 | 2022-08-07 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12